The AHA today urged the Department of Health and Human Services to take a number of regulatory actions that would help hospitals and health systems better prepare for and respond to the novel coronavirus (COVID-19) outbreak. Among other actions, AHA urged HHS to enable broader use of telehealth and help preserve the supply of N95 respirators.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA, health organizations letter to Senate Chairman, Lamar Alexander and Ranking Member Patty Murray, expressing supportĀ of S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act.
Ā AHA, health organizations letter toĀ Representatives Peters, Engel, Eshoo, Schrader, Guthrie, Hudson, McCaul, and Bilirakis,Ā supporting theĀ Preventing Drug Shortages Act.Ā
AHA comments on the Centers for Medicare & Medicaid Services's (CMS), Part II of the Medicare Advantage (MA) and Part D Advance Notice. In particular, the AHA appreciates the CMSā ongoing efforts to solicit stakeholder feedback on how to improve the MA Star Ratings Program, and we encourage the agency to develop and incorporate into that program measures related to prior authorization.
AHA comments to CMS on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021.
The AHA and American Nurses Association urge Congress to āswiftly provideā $1 billion in initial supplemental emergency funding to support the āurgent preparedness and response needs of hospitals, health systems, physicians and nurses on the front linesā of the novel coronavirus outbreak.
AHA letter to Senators Rick Scott, R-Fla., Marco Rubio, R-Fla., and Tom Cotton, R-Ark., in respond to their questions on efforts to protect U.S. taxpayer-funded research developed at our member organizations from foreign threats.
AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).
AHA comments to theĀ U.S. House of Representatives Committee on Education and Labor on provisions of theĀ Ban Surprise Billing Act that will be marked up this week.
The AHA is pleased to support the U.S. House of Representatives Committee on Ways and Means legislation, the Consumer Protections Against Surprise Medical Bills Act of 2020.Ā